Adverse events · solid organ transplant recipients
Maribavir showed no clear difference in adverse events compared with ganciclovir (moderate certainty).
1 finding from 1 review
Graft loss · solid organ transplant recipients
Antiviral prophylaxis showed no clear difference in graft loss compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Acute rejection · solid organ transplant recipients
Antiviral prophylaxis showed no clear difference in acute rejection compared with placebo or no treatment (high certainty).
1 finding from 1 review
Leucopenia · solid organ transplant recipients
Antiviral prophylaxis showed no clear difference in leucopenia compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Kidney dysfunction · solid organ transplant recipients
Antiviral prophylaxis showed no clear difference in kidney dysfunction compared with placebo or no treatment (low certainty).
1 finding from 1 review
CMV disease · solid organ transplant recipients
Ganciclovir leads to lower CMV disease compared with aciclovir (high certainty).
1 finding from 1 review
Fatal cardiovascular events (percentage of people having fatal cardiovascular events) · people with established arterial occlusive events
Mobile phone text messaging showed no clear difference in fatal cardiovascular events (percentage of people having fatal… compared with usual care (low certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · people with established arterial occlusive events
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Combined cardiovascular events · people with established arterial occlusive events
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Low‐density lipoprotein cholesterol (mg/dL) (endpoint low‐density lipoprotein cholesterol reading) · people with established arterial occlusive events
1 finding from 1 review
Blood pressure · people with established arterial occlusive events
1 finding from 1 review
Heart rate · people with established arterial occlusive events
1 finding from 1 review
Number of continuously abstinent women ‐ total · stopping or reducing alcohol consumption during pregnancy
Summary of findings table ‐ Any psychosocial intervention may leads to higher number of continuously abstinent women ‐ total compared with treatment (low certainty).
1 finding from 1 review
Number of drinks per day ‐ total · stopping or reducing alcohol consumption during pregnancy
1 finding from 1 review
Number of women who completed treatment ‐ total · stopping or reducing alcohol consumption during pregnancy
Summary of findings table ‐ Any psychosocial intervention showed no clear difference in number of women who completed treatment ‐ total compared with treatment (moderate certainty).
1 finding from 1 review
Adverse events ‐ not measured · stopping or reducing alcohol consumption during pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawal signs and symptoms ‐ not measured · stopping or reducing alcohol consumption during pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mental state · schizophrenia
1 finding from 1 review
Risk for at least one adverse event per patient · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes adverse events ‐ Participants with at least one AE (separated time… compared with antipsychotics (very low certainty).
1 finding from 1 review
Mental state · schizophrenia
1 finding from 1 review